PCM
NAGE

Prelude Capital Management’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History

Prelude Capital Management’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-15,474
Closed -$82.1K – 1466
2024
Q4 		$82.1K Buy
+15,474
New +$82.1K 0.01% 983